Research into rare diseases gets a funding boost from the NIH: UAB researchers studying Rett syndrome and tuberous sclerosis among those involved in the national effort.
Hospitals remain alert and ready after a confirmed U.S. hospital-identified case of imported Ebola associated with the ongoing West African outbreak makes news in Dallas.
UAB clinical collaboration with CVS/pharmacy and MinuteClinic will increase access to care and help improve medication adherence for patients.
Sixteen clinical centers and 30 hospitals will enroll up to 5,700 pregnant women to evaluate the benefits and harms of pharmacologic treatment of mild chronic hypertension in pregnancy.
The $25 service, available to adults 18 and older in the Birmingham area, combines the expertise of UAB Medicine providers with the convenience of online access.
If successful, the PRESERVE-1 trial could be a significant clinical breakthrough in the treatment of the condition by prolonging pregnancy and improving outcomes.
Since December, 21 living donor kidney transplants that have taken place at UAB are connected as donors “pay it forward” for a recipient to keep the chain going, and more transplants are scheduled for July.
UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Neurologist David Geldmacher, M.D., is launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
An inside pitch and a slip off the bat deliver a potentially blinding blow -- and a message for vision safety.